News Novartis matches Gilead on price in new CAR-T use Novartis won't offer 'money back' scheme because of delayed effect
News Mundipharma to market Herceptin biosimilar in key EU markets Mundipharma's third biosimilar tie-up with Celltrion
News MSD launches first Herceptin biosimilar in UK Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD.
News Its Herceptin biosimilar nearing launch, Celltrion begins wo... South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda.
News Biosimilar onslaught will slow Roche down in 2018 Roche has recorded a successful full year 2017, with sales driven by MS drug Ocrevus and cancer treatments Tecentriq, Perjeta and Alecensa, helping it to boost overall sales by 5% to C
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
